Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine.

Thielmann, Matthias

Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine. [electronic resource] - Circulation research Apr 2002 - 807-13 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1524-4571

10.1161/01.res.0000014451.75415.36 doi


Amidohydrolases--antagonists & inhibitors
Animals
Apoptosis--drug effects
Blood Flow Velocity
Ceramidases
Coronary Circulation
Coronary Disease--etiology
Disease Models, Animal
Dogs
Embolism--complications
Endocannabinoids
Enzyme Inhibitors--pharmacology
Ethanolamines--pharmacology
Leukocyte Count
Microspheres
Myocardial Contraction--drug effects
Myocardium--metabolism
NG-Nitroarginine Methyl Ester--pharmacology
Nitric Oxide--metabolism
Nitric Oxide Synthase--antagonists & inhibitors
Nitric Oxide Synthase Type II
Oleic Acids
RNA, Messenger--metabolism
Signal Transduction--drug effects
Sphingosine--metabolism
Tumor Necrosis Factor-alpha--metabolism